Moran Artzi1, Gilad Liberman2,3, Deborah Blumenthal4, Felix Bokstein4, Orna Aizenstein1, and Dafna Ben Bashat1,5
1Functional Brain Center, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, 2Functional Brain Centerasky Medical Cente, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, 3Department of Chemical Physics, Weizmann Institute, Rehovot, Israel, 4Neuro-Oncology Service, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, 5Sackler Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel-Aviv, Israel
Synopsis
Segmentation
of lesion area in patients with glioblastoma (GB) into active tumor,
tissue necrosis, vasogenic edema and infiltrative disease, is highly
important for patient monitoring, yet is challenging using standard radiological
assessment. The aim of this study was to segment the lesion area into these
four tissue types in GB patients. Voxel-wise classification was performed using
support-vector-machine based on anatomical and DCE-MRI parameters. Significant differences were detected between the tissue
types for FLAIR, vp, and ktrans. Sensitivity
and specificity of the training-set were measured based on 2-fold-cross-validation
analysis, showing high sensitivities and
specificities of 94-100% for the different tissue types.PURPOSE
Glioblastoma
(GB) is the most common and aggressive brain tumor in adults, and is
characterized by a high heterogeneity within the lesion area. Lesion
segmentation and classification into different tissue types, are highly
important for patient diagnosis and follow up, yet is challenging using standard
radiological assessment
[1-3].
The aim of this study was to segment the enhanced and non-enhanced lesion areas
and to classify them into active tumor, tissue necrosis, vasogenic edema and
infiltrative disease in patients with GB, based on
anatomical images and dynamic contrast enhanced MRI (DCE-MRI).
METHODS
Patients
and MRI Protocol: A total of 27 MRI scans obtained from fifteen patients with
biopsy-proven GB were included in this study. Scans were performed on 3.0 T GE (Signa
Horizon) / Siemens (Prisma) systems and included: T1 weighted (T1W)
imaging, performed before and after contrast agent (Gd) injection; FLAIR images;
and DCE, acquired using multi-phase 3D SPGR / FLASH imaging with
the variable flip angle (VFA) method used for T1 map calculation.
Preprocessing:
included skull stripping, inhomogeneity correction and realigning of all
anatomical images to the DCE space. T1W+Gd and FLAIR images were
normalized relative to the normal appearing white matter. Plasma volume (vp)
and the volume transfer constant (ktrens) parameters were
calculated from the DCE data using DUSTER (DCE-Up-Sampled-TEmporal Resolution),
an in-house tool for DCE analysis, based on the Extended-Tofts-Model [4] with T1 maps calculated
with correction of inaccuracy in the flip angles and accounting for differences
in the bolus arrival time [5, 6].
Model selection was applied similarly to Bagher-Ebadian [7].
Segmentation and
classification: First, the enhanced and non-enhanced lesion areas were
extracted from the T1W+Gd and FLAIR images using threshold-based
segmentation similar to [8] (Fig. 1a,b). Next, classification of the enhanced area into active tumor or necrosis and of the non-enhanced
lesion area into vasogenic edema or infiltrative disease were
performed using Matlab support
vector machine (SVM) classifier (Fig. 1c). The
input data for classification were the normalized T1W+Gd,
FLAIR images, and the DCE vp, and ktrens maps. Training data of active tumor (22 data sets), necrosis (8
data sets), vasogenic edema (26 data sets) and infiltrative disease (19 data sets) were manually defined retrospectively and approved
by a senior neuro-radiologist, based on longitudinal MRI of the patients. Sensitivity
and specificity of the training set were measured based on two-fold cross
validation analysis.
RESULTS
Lesion segmentations and voxel-wise classification of
the entire lesion area were successfully performed in all scans (n=27). Significant differences (p<0.05) were detected between
the active tumor compared to necrosis with higher vp and ktrans
values detected for the active tumor, and between the vasogenic edema compared to
infiltrative disease with lower FLAIR, and higher vp and ktrans
values detected for the infiltrative disease (Table1).
Validation: The classification of the SVM training data produced high sensitivities
and specificities of: 97% / 94% for active tumor; 100% / 100% for necrosis; 98%
/ 97% for vasogenic edema and 95% / 96% for
infiltrative disease. Figure 2 demonstrates data
obtained from a patient with GB, scanned at time points #1 (top row), and #2 (bottom
row), two months later. In this case, conventional imaging showed a mild increase of 19% of the enhanced lesion area, and a decrease of 22%
of the non-enhanced lesion area, indicating stable disease according to RANO criteria
[1]. However, the SVM segmentation results showed a marked increase of 90% in the active tumor
and of 50% in the infiltrative disease components, supporting disease progression. Follow-up
scans of this patients demonstrated further progression.
DISCUSSION
& CONCLUSION
The
current work aimed to tackle major radiological challenges of differentiating
active tumor from necrosis and vasogenic edema from infiltrative disease in
patients with GB. In this study automatic
segmentation of lesion area and classification into four tissue types were
performed using threshold based segmentation and SVM classifier, based on conventional imaging and DCE-MRI
vascular parameters. In comparison to dynamic
susceptibility contrast (DSC) which is usually used for assessment of brain
tumors, DCE is less sensitive to susceptibility artifacts, acquired with higher
spatial resolution, and provides quantitative information of different vascular
properties within the tissue, including permeability. The two-stage process applied in this study showed
high sensitivity and specificity, can provide volumetric information about changes
in lesion components over time, and thus may be used in routine clinical
practice to improve patient diagnosis and therapy response assessment.
Acknowledgements
To Faina Vitinshtein and
Tuvia Genot for assistance in patient recruitment and MRI scansReferences
[1] Wen, P.Y., et al., Updated response assessment criteria for high-grade
gliomas: response assessment in neuro-oncology working group. J Clin Oncol,
2010. 28(11): p. 1963-72; [2] Brandes, A.A., et al., Disease progression or pseudoprogression
after concomitant radiochemotherapy treatment: pitfalls in neurooncology.
Neuro Oncol, 2008. 10(3): p. 361-7; [3] Verma, N., et al., Differentiating tumor recurrence from
treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro
Oncol, 2013. 15(5): p. 515-34; [4] Tofts, P.S. ., et al., Measurement of the blood-brain barrier
permeability and leakage space using dynamic MR imaging. 1. Fundamental
concepts. MRM, 1991. 17(2): p. 357-67; [5] Liberman, G. , et al., T1 Mapping Using Variable Flip Angle SPGR
Data With Flip Angle Correction. Journal of MRI, 2013; [6] Liberman, G., et al., Bolus Arrival Time extraction using Super
Temporal Resolution Analysis of DCE; ISMRM 2014: Milan, Italy; [7] Bagher-Ebadian, H., et al., Model selection for DCE-T1 studies in
glioblastoma. MRM, 2012. 68(1): p. 241-51; [8] Artzi, M., et al., FLAIR lesion segmentation: application in
patients with brain tumors and acute ischemic stroke. Eur J Radiol, 2013.
82(9): p. 1512-8.